Diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis
Alimentary Pharmacology and Therapeutics | Aug 11, 2017
Zagari RM, et al. – This meta–analysis aspired to evaluate the diagnostic performance of the serum panel test for the diagnosis of atrophic gastritis. For the diagnosis of atrophic gastritis, the combination of pepsinogen, gastrin–17, and anti–H. pylori antibodies serological assays appeared to be a reliable tool. For screening subjects or populations at high risk of gastric cancer for atrophic gastritis, this test could be used. However, a cost–effectiveness analysis was required.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries